MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
miRagen Therapeutics and Signal Genetics Sign Merger Agreement.
Brennan CaruthersOctober 31, 2016
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

miRagen Therapeutics Announces Presentation of MRG-106 Clinical Data at American Society of Hematology Annual Meeting.

Brennan CaruthersNovember 3, 2016
Next

miRagen Therapeutics Appoints Kevin Koch, Ph.D., to Its Board of Directors.

Brennan CaruthersSeptember 9, 2016

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact